Granahan Investment Management, LLC
Position in KNSA — Kiniksa Pharmaceuticals International, plc
CIK 1026710
WALTHAM, MA
Position in KNSA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,702,813
-$372,863 QoQ
Shares Held
151,725
-27.5% QoQ
Ownership
0.097%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#53
of 266 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in KNSA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Granahan Investment Management, LLC holds $16,820,936 across 2 Drug Manufacturers - Specialty & Generic names. KNSA ranks #1 (57.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
This page
|
151,725 | $9,702,813 | |
| 2 | XERS |
Xeris Biopharma Holdings, Inc.
|
898,753 | $7,118,123 |
All Filings in KNSA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,702,813 | 151,725 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $10,075,676 | 209,256 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,043,786 | 316,213 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $11,011,061 | 283,571 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,605,148 | 310,992 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,037,665 | 361,894 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,160,315 | 463,110 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $12,679,151 | 507,369 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,618,282 | 568,735 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||